Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction

Angiology

Volumn 66, Issue 2, 2015, Pages 155-162

  Celik, Turgay ^a   Kaya, Mehmet G ^b   Akpek, Mahmut ^b   Gunebakmaz, Ozgur ^b   Balta, Sevket ^a   Sarli, Bahadir ^b   Duran, Mustafa ^b   Demirkol, Sait ^a   Uysal, Onur Kadir ^b   Oguzhan, Abdurrahman ^b   Gibson, C Michael ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

In hospital prognosis; Mean platelet volume; Platelet distribution width; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; TIROFIBAN;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG ELUTING CARDIOVASCULAR STENT; FEMALE; GLUCOSE BLOOD LEVEL; GUIDING CATHETER; HOSPITAL ADMISSION; HUMAN; INTRACORONARY DRUG ADMINISTRATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NO REFLOW PHENOMENON; PLATELET DISTRIBUTION WIDTH; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYSTEMIC THERAPY; THROMBOCYTE FUNCTION AND CHARACTERISTICS; THROMBOCYTE VOLUME; TRANSLUMINAL CORONARY ANGIOPLASTY; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; BLOOD; CHI SQUARE DISTRIBUTION; CORONARY THROMBOSIS; DEVICES; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; RISK; RISK FACTOR; STATISTICAL MODEL; STENT; TIME; TREATMENT OUTCOME; TURKEY;

AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; ODDS RATIO; PATIENT ADMISSION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 84925582062     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713513493     Document Type: Article

References (34)

1. Galasso G, Schiekofer S, D'Anna C, et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. a review of the current literature and future perspectives. Angiology. 2014; 65(3):180-189. doi: 10.1177/0003319712474336.
2. Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873-882.
3. Butler MJ, Chan W, Taylor AJ, Dart AM, Duffy SJ. Management of the no-reflow phenomenon. Pharmacol Ther. 2011;132(1): 72-85.
4. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. phase I findings. N Engl J Med. 1985;312(14): 932-936.
5. Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;109(4): 486-491.
6. Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012; 110(5):621-627.
7. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2006;3(9):499-506.
8. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes following thrombolytic administration. thrombolysis in myocardial infarction (TIMI) study group. Circulation. 1999;99(15):1945-1950.
9. Mehta RH, Harjai KJ, Boura J, et al. Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2003;92(12):1445-1447.
10. Engler RL. Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion. Am J Cardiol. 1989; 63(10):19E-23E.
11. Kaya MG, Akpek M, Lam YY, et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol. 2013;168(2): 1154-1159.
12. Akpek M, Elcik D, Kalay N, et al. The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology. 2012;63(8): 579-585.
13. Dreyer WJ, Michael LH, West MS, et al. Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation. 1991;84(1):400-411.
14. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005;46(2):284-290.
15. Reffelmann T, Kloner RA. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006;101(5):359-372.
16. Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in myocardial infarction. Br Med J. 1983; 287(6390):456-459.
17. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983;32(5):443-460.
18. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med. 1983;101(2):205-213.
19. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994;24(1):69-72.
20. Jagroop IA, Mikhailidis DP. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation. Clin Appl Thromb Hemost. 2008;14(3):295-302.
21. Cameron HA, Phillips R, Ibbotson RM, Carson PH. Platelet size in myocardial infarction. Br Med J. 1983;287(6390):449-451.
22. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011;219(1):334-341.
23. Yaşar AS, Bilen E, Yüksel IO, et al. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction. Turk Kardiyol Dern Ars. 2010;38(2):85-89.
24. Estévez-Loureiro R, Salgado-Fernández J, Marzoa-Rivas R, et al. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res. 2009;124(5):536-540.
25. Avramakis G, Papadimitraki E, Papakonstandinou D, et al. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets. 2007;18(1):16-23.
26. Maden O, Kacmaz F, Selcuk H, et al. Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions. Can J Cardiol. 2009;25(6):e164-e168.
27. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47-58.
28. Boos CJ, Beevers GD, Lip GY. Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension. Ann Med. 2007;39(1):72-78.
29. Van Cott EM, Fletcher SR, Kratz A. Effects of the bloodcollection tube material and long-term storage on platelet activation parameters on the ADVIA 120/2120 hematology system. Lab Hematol. 2005;11(1):71-75.
30. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1):28-32.
31. Akpek M, Kaya MG, Yarlioglues M, et al. Relationship between platelet indices and spontaneous echo contrast in patients with mitral stenosis. Eur J Echocardiogr. 2011;12(11):865-870.
32. De Luca G, Venegoni L, Iorio S, et al. Platelet distribution width and the extent of coronary artery disease: results from a large prospective study. Platelets. 2010;21(7):508-514.
33. Boos CJ, Balakrishnan B, Lip GY. The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood. J Thromb Thrombolysis. 2008; 25(2):135-140.
34. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35(7):1688-1691.